Delivery Order SPE2DB22D2005-SPE2DB25FJNF8
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% in a 400 mg/200 ml dosage format. This firm fixed-price delivery order, valued at $2,818.62, represents a non-competitive set-aside procurement and is scheduled for completion by June 20, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units, with a ceiling value of $2,147.31. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $3,428.19 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.08 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 mL in 200 mL units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 2, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Ropivacaine 0.5% 150 mg/30 mL in 30 mL quantities, with a ceiling value of $5,786.97. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of May 13, 2025, and no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 ml doses, with a contract ceiling value of $5,062.74 and an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,646.08 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% in a 400 mg/200 mL concentration with a ceiling value of $1,529.13. This competitive, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ropivacaine is a local anesthetic used in medical and surgical procedures, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 ml in 100 ml quantities, with a contract ceiling value of $5,432.13 and an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJNF8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive IDC with the DLA. The company's portfolio demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains, ranging from specialty medications and brand-name drugs to vaccines and medical supplies. This particular delivery order for Ropivacaine, a local anesthetic commonly used in medical procedures, exemplifies the company's role in supporting military and federal healthcare operations through the DLA's Troop Support Medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/5/25 |